Genetics Generation Advancement Corp. (4160.TWO)
Taipei Exchange · TWD · Healthcare · Diagnostics & Research
NT$36.45 (-2.15%) as of
Key statistics
- Market cap
- 1.02B
- P/E (TTM)
- 56.08
- EPS (TTM)
- 0.65
- Dividend yield
- 0.00%
- 52-week range
- 36.45 – 55.93
- Beta
- 0.33
- Revenue (TTM)
- 614.42M
- Profit margin
- 2.92%
- Volume
- 41.07k
About Genetics Generation Advancement Corp.
Genetics Generation Advancement Corp. engages in the development and implementation of digital data management systems for gene testing, biological, chemical, and materials information in Taiwan. The company offers testing services, such as pre-implantation, prenatal stage, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology, neonatology and pediatrics, oncology, and medical research services. It also provides AI and data applications, such as bioinformatic, materials sciences, research and development management, enterprise quality management, process production operation, e-submission, tech record, biological simulation, and einfotree_excel products. The company was formerly known as Genesis Genetics Asia Corp. and changed its name to Genetics Generation Advancement Corp. in February 2016. Genetics Generation Advancement Corp. was founded in 2008 and is based in Taipei City, Taiwan.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.